Logo - Business Development Bank of Canada - BDC
Celator Pharmaceuticals Inc. logo
Exited company

Celator Pharmaceuticals Inc.

Industry sector
Investment year
Diversified Portfolio
Learn more
About the company

Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies designed to target cancer cells. The company’s lead product is in clinical development for the treatment of acute myeloid leukemia.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.